TRxADE HEALTH (MEDS) Appoints Jeff Newell to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
TRxADE HEALTH, INC. Appoints Leading Pharmaceutical Industry Expert Mr. Jeff Newell to its Advisory Board
August 16, 2022 7:31 AM EDTTAMPA, FL / ACCESSWIRE / August 16, 2022 / TRxADE HEALTH, INC. (NASDAQ: MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., announced today the appointment of Jeff Newell to the Company's advisory board. Mr. Newell is expected to serve as a strategic resource to TRxADE as it continues to develop trade relationships in the industry.
"We are thrilled to add industry experts like Mr. Newell to the Advisory Board... More
